The global frontotemporal disorder treatment market is projected to grow at a considerable CAGR of around 5% during the forecast period (2020-2026). The increasing prevalence of frontotemporal disorder along with the growing geriatric population which is more susceptible to this kind of disorder is expected to be key factors promoting the growth of the global frontotemporal disorder treatment market. According to the World Health Organization (WHO), in 2019 around 50 million people are living with dementia and the number is anticipated to get three times by 2050. Moreover, nearly 10 million new cases are anticipated to increase every year. Frontotemporal disorders are forms of dementia caused by a family of brain disorders known as frontotemporal lobar degeneration (FTLD).
Get Free Sample Copy @ https://www.omrglobal.com/request-sample/frontotemporal-disorder-treatment-market
With the growing number of patients suffering from the frontotemporal disorder, several private or non-profit organizations are actively focusing on drug development procedures. For instance, in 2019, the National Institute of Health (NIH) had spent nearly $387 million on research projects for Alzheimer's Disease-Related Dementias (ADRD). Therefore, the rising funding initiatives by a non-profit organization such as the Bluefield Project Organization, CurePSP, Inc. Alzheimer Discovery Foundation (ADDF), Tau Consortium Organization, Association for Frontotemporal Degeneration (AFTD) to support drug research initiatives is anticipated to drive the growth of the frontotemporal disorder treatment industry across the globe. However, stringent government regulations, lack of awareness, and lack of novel therapies are the key factors anticipated to hinder the growth of the global market.
Browse for Full Report Description@ https://www.omrglobal.com/industry-reports/frontotemporal-disorder-treatment-market
Market Segmentation
Global Frontotemporal Disorders Treatment Market by Drug Class
• Cognitive Enhancers
• Antipsychotics
• Antidepressants
• CNS Stimulant
• Other
Global Frontotemporal Disorders Treatment Market by Disease Indication
• Frontotemporal Dementia
• Primary Progressive Aphasia
• Movement Disorder
Global Frontotemporal Disorders Treatment Market by Distribution Channel
• Hospital Pharmacies
• Retail Pharmacies
• Others
Regional Analysis
North America
• US
• Canada
Europe
• UK
• Germany
• Italy
• Spain
• France
• Rest of Europe
Asia-Pacific
• China
• India
• Japan
• Rest of Asia-Pacific
Rest of the World
Company Profiles
• Allergan PLC
• Apotex Inc.
• AstraZeneca PLC
• Bausch Health Companies, Inc.
• Eli Lily and Co.
• F. Hoffmann-La Roche Ltd.
• GlaxoSmithKline PlPLC
• Intas Pharmaceutical Ltd.
• Johnson & Johnson Service, Inc.
• Merck & Company, Inc.
• Mylan N.V.
• Novartis AG
• Pfizer, Inc.
• Sanofi S.A.
• Teva Pharmaceuticals Industries, Ltd.
For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/frontotemporal-disorder-treatment-market
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: [email protected]
Contact no: +91 780-304-0404